Literature DB >> 2463837

Analysis of the structure and expression of the c-myc oncogene in cervical tumor and in cervical tumor-derived cell lines.

K B Choo1, K Y Chong, H F Chou, L N Liew, C C Liou.   

Abstract

The structure of the c-myc oncogene in 17 cervical tumors and patient-matched nontumor tissues from Chinese patients residing in Taiwan was analysed. In contrast to recent reports on Mexican patients, none of the samples showed rearrangements and sequence amplification in the c-myc gene. The discrepancy may be explained by different carcinogenesis mechanisms being in operation in different geographic regions. Although no structural alterations in the c-myc gene were found in seven cervical carcinoma cell lines analysed, Northern blot analysis indicated different levels of c-myc gene expression which may be related to the presence of human papillomavirus (HPV) sequence in the cell and suggests a possible c-myc-hpv interaction in some stages of the transformation process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2463837     DOI: 10.1016/s0006-291x(89)80217-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Newly established uterine cervical carcinoma cell line with co-amplification of human papillomavirus DNA and c-myc gene.

Authors:  M Gotoh; T Nakajima; J Yokota; Y Tsunokawa; M Terada; Y Shimoyama; S Teshima; S Hirohashi; Y Shimosato
Journal:  Jpn J Cancer Res       Date:  1991-11

2.  Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.

Authors:  W Nürnberg; M Artuc; G Vorbrueggen; F Kalkbrenner; K Moelling; B M Czarnetzki; D Schadendorf
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.